Pharmaceutical — All Publications

Access to Covid-19 Vaccines: the Patent Freeze Proposal and a New Global Strategy

As the vaccination rate rises in Canada and other developed nations, developing countries globally continue to record an upsurge in daily infection and death rates due to COVID-19. Prime Minister Justin Trudeau recently confirmed that Canada is involved in the World Trade Organization’s (WTO) exploration of the Indian and South African proposal to waive intellectual property (IP) rights for COVID-19 vaccines. In a break from tradition, United States President Joe Biden has lent his country’s support to the initiative, amidst reluctance to do the same from the EU. However, Canada remains ambivalent.

Blog PostChidi OguamanamJuly 6, 2021COVID-19, Vaccine, Patent, WHO, South Korea, South Africa, European Union, Pharmaceutical, Health Law and Medical Ethics

COVID-19: In the Shadow of Ebola, the Patent War to Come and a Forgotten Africa

In the midst of the COVID-19 pandemic, the world continues to overlook the epidemic raging on in some of the poorest regions of Africa since 2013: the Ebola outbreak. The Ebola virus is a severe disease with a death rate of up to 90% in humans. The virus was first identified in 1976 with two simultaneous outbreaks; one in the Yambuku village in the Democratic Republic of the Congo (DRC) and the other in a remote area of Sudan.

Blog PostChidi OguamanamMay 22, 2020Ebola, Africa, COVID-19, DRC, Médecins Sans Frontières, WHO, United Nations, Canada, Health Law and Medical Ethics, Guinea, Liberia, China, Costa Rica, Chile, Kenya, Pharmaceutical

ALL PUblications